ANXA2 Silencing Inhibits Proliferation, Invasion, and Migration in Gastric Cancer Cells

Abstract EN

Annexin A2 (ANXA2) has been well known to associate with the progress of malignant tumor.

However, the biological behavior of ANXA2 in gastric cancer (GC) remains unclear.

We made a hypothesis in transcriptome level from TCGA datasets.

Then, we used immunohistochemical staining to quantify the expression level of ANXA2 protein in GC tissues compared with adjacent tissues.

Quantitative real-time PCR and western blot were used for analyzing ANXA2 expression in human GC (SGC-7901, MKN-45, BGC-823, and AGS) cell lines.

We investigated the effect of a lentivirus-mediated knock-down of ANXA2 on the proliferation, invasion and migration of gastric cancer AGS cells.

Cell proliferation was examined by MTT and colony formation tests.

Cell apoptosis and cycle were measured by flow cytometry.

Migration and invasion were detected by transwell assay.

We found that high expression of ANXA2 can increase the mobility of cancer cells from TCGA datasets.

ANXA2 was upregulated in GC tissues compared with adjacent tissues.

AGS cell line displayed significantly higher expression of ANXA2 among the four GC cell lines.

In addition, ANXA2 silencing led to a weakened ability of proliferation, invasion, and migration in GC cells; targeting of ANXA2 may be a potential therapeutic strategy for GC patients.